Omnicell (OMCL) Scheduled to Post Quarterly Earnings on Thursday

Omnicell (NASDAQ:OMCL) is scheduled to issue its quarterly earnings data before the market opens on Thursday, August 1st. Analysts expect the company to announce earnings of $0.16 per share for the quarter. Omnicell has set its Q2 guidance at $0.10-0.20 EPS and its FY24 guidance at $0.90-1.40 EPS.Parties that wish to register for the company’s conference call can do so using this link.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, May 2nd. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.17. Omnicell had a positive return on equity of 2.41% and a negative net margin of 1.91%. The firm had revenue of $246.15 million during the quarter, compared to the consensus estimate of $235.70 million. On average, analysts expect Omnicell to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Omnicell Price Performance

OMCL stock opened at $29.39 on Wednesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.13 and a current ratio of 2.38. The stock’s 50 day moving average price is $28.62 and its 200 day moving average price is $28.99. The firm has a market cap of $1.35 billion, a P/E ratio of -63.89, a PEG ratio of 83.15 and a beta of 0.80. Omnicell has a 1 year low of $25.12 and a 1 year high of $66.65.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Benchmark restated a “buy” rating and issued a $38.00 price objective on shares of Omnicell in a research report on Monday, July 15th. StockNews.com cut shares of Omnicell from a “buy” rating to a “hold” rating in a research note on Tuesday, July 16th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Omnicell presently has an average rating of “Hold” and a consensus price target of $42.20.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.